Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email: bcfdn@aol.com  
Bone and Cancer

Clinical Trials

Tavist (clemastine fumarate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved November 1996

Specific Treatments:

cold symptoms, including sneezing and runny nose

General Information

Tavist-D has been approved for the treatment of cold symptoms, including sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others.

 How To Order Publications:
  Glossary
  FAQ

Information About

Clinical Trials



 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 


  Copyright 2011 - The Bone and Cancer Foundation